Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BNIP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | CALML3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | ZDHHC3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | KRT82 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | HPDL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | CYP3A7-CYP3A51P | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | LGALS3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | DNAJB4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | KIR2DL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | C1orf116 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |